Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Exertional	O
chest	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
man	O
with	O
stage	O
II	O
(T2aN1M0)	O
squamous	O
cell	O
lung	O
carcinoma	O
s/p	O
chemo/XRT	O
(last	O
___	O
in	O
remission,	O
COPD,	O
paroxysmal	O
afib,	O
and	O
newly	O
diagnosed	O
renal	O
mass	O
pending	O
biopsy.	O
He	O
presented	O
to	O
___	O
for	O
renal	O
biopsy	O
today	O
and	O
told	O
the	O
physicians	O
there	O
that	O
he	O
has	O
been	O
having	O
exertional	O
chest	O
pain	O
so	O
sent	O
to	O
ED	O
for	O
further	O
evaluation	O
Patient	O
reports	O
exertional	O
fatigue	O
and	O
burning	O
central	O
chest	O
pain	O
which	O
improves	O
with	O
rest,	O
sometimes	O
associated	O
with	O
radiation	O
to	O
the	O
jaw,	O
and	O
worsening	O
dypsnea	O
on	O
exertion.	O
This	O
has	O
been	O
going	O
on	O
for	O
the	O
past	O
___	O
months	O
and	O
he	O
has	O
been	O
referred	O
for	O
a	O
stress	O
test	O
on	O
multiple	O
occasions	O
but	O
has	O
missed	O
his	O
appointments	O
due	O
to	O
other	O
systemic	O
illness.	O
He	O
reports	O
that	O
his	O
exertional	O
symptoms	O
are	O
not	O
worse	O
than	O
prior.	O
Of	O
note,	O
patient	O
was	O
recently	O
seen	O
by	O
his	O
oncologist	O
and	O
was	O
noted	O
have	O
generalized	O
fatigue	O
and	O
weakness	O
and	O
poor	O
exercise	O
tolerance.	O
He	O
was	O
found	O
to	O
have	O
a	O
left	O
6cm	O
renal	O
mass	O
that	O
was	O
concerning	O
for	O
malignancy,	O
either	O
lymphoma,	O
collecting	O
duct	O
carcinoma,	O
or	O
urothelial	O
carinoma.	O
Metastasis	O
or	O
RCC	O
felt	O
to	O
be	O
less	O
likely.	O
He	O
was	O
scheduled	O
for	O
a	O
renal	O
biopsy	O
by	O
___	O
for	O
evaluation.	O
Of	O
note,	O
patient	O
was	O
recently	O
admitted	O
for	O
c.	O
diff	O
colitis,	O
completed	O
course	O
of	O
PO	O
vancomycin	O
on	O
___.	O
He	O
denies	O
any	O
fever/chills,	O
n/v.	O
He	O
has	O
occasional	O
left	O
lower	O
abdominal	O
pain	O
and	O
one	O
episode	O
of	O
non-bloody	O
diarrhea	O
x	O
1	O
in	O
the	O
ED.	O
In	O
the	O
ED,	O
initial	O
VS	O
were:	O
97.8	O
___	O
18	O
97%	O
RA	O
Labs	O
showed:	O
140|102|22	O
----------<	O
98	O
4.6|25|1.1	O
MB	O
1	O
Trop	O
<0.01	O
9.8	O
6.6	O
>---<	O
185	O
30.4	O
Imaging	O
showed:	O
CXR	O
with	O
no	O
signs	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
Right	O
hilar	O
and	O
perihilar	O
scarring	O
similar	O
to	O
the	O
prior	O
CT.	O
Consults:	O
none	O
Patient	O
received:	O
+	O
Albuterol	O
neb	O
+	O
Ipratropium	O
neb	O
+	O
Pravastation	O
+	O
Metop	O
XL	O
25	O
+	O
Omeprazole	O
20	O
Transfer	O
VS	O
were:	O
98.5	O
108	O
120/73	O
18	O
96%	O
RA	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
denies	O
CP	O
currently.	O
Does	O
have	O
DOE.	O
REVIEW	O
OF	O
SYSTEMS:	O
10	O
point	O
ROS	O
reviewed	O
and	O
negative	O
except	O
as	O
per	O
HPI	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
--In	O
___,	O
the	O
patient	O
noted	O
a	O
cough	O
that	O
was	O
productive	O
of	O
sputum,	O
no	O
hemoptysis	O
noted.	O
The	O
cough	O
worsened,	O
and	O
he	O
ended	O
up	O
going	O
to	O
___	O
ER	O
where	O
he	O
was	O
given	O
antibiotics	O
and	O
improved.	O
He	O
ended	O
up	O
getting	O
a	O
chest	O
x-ray	O
that	O
was	O
obtained	O
on	O
___	O
that	O
showed	O
interval	O
soft	O
tissue	O
fullness	O
of	O
the	O
right	O
hilum.	O
--A	O
subsequent	O
CT	O
scan	O
was	O
obtained	O
on	O
___	O
and	O
that	O
showed	O
a	O
cavitary	O
right	O
hilar	O
mass	O
extending	O
into	O
the	O
upper	O
lobe,	O
highly	O
suspicious	O
for	O
malignancy.	O
He	O
was	O
then	O
referred	O
here	O
to	O
___	O
for	O
multidisciplinary	O
thoracic	O
care	O
--___:	O
he	O
underwent	O
bronchoscopy,	O
which	O
showed	O
a	O
right	O
upper	O
lobe	O
endobronchial	O
lesion,	O
biopsy	O
of	O
the	O
lesion	O
as	O
well	O
as	O
EBUS	O
with	O
TBNA	O
of	O
4L,	O
7	O
and	O
11R	O
were	O
done.	O
He	O
also	O
had	O
cauterization	O
of	O
the	O
right	O
upper	O
lobe	O
endobronchial	O
lesion.	O
The	O
results	O
from	O
that	O
procedure	O
showed	O
that	O
the	O
lesion	O
was	O
an	O
invasive	O
squamous	O
carcinoma.	O
FNA	O
of	O
level	O
7	O
and	O
lymph	O
node	O
was	O
negative,	O
level	O
4L	O
was	O
negative,	O
but	O
11R	O
was	O
positive.	O
--___:	O
.	O
Mediastinoscopy	O
___	O
with	O
2	O
level	O
7	O
and	O
2	O
4Rs	O
were	O
biopsied	O
which	O
were	O
negative	O
for	O
malignancy.	O
He	O
was	O
staged	O
IIa	O
(T2aN1M0)	O
--___:	O
Dr.	O
___	O
further	O
imaging	O
including	O
a	O
recent	O
contrast	O
CT,	O
which	O
showed	O
the	O
proximity	O
of	O
the	O
tumor	O
to	O
the	O
right	O
main	O
pulmonary	O
artery,	O
raising	O
concern	O
that	O
he	O
would	O
require	O
pneumonectomy.	O
Given	O
the	O
patient's	O
symptoms,	O
poor	O
performance	O
status	O
and	O
PFTs	O
Dr.	O
___	O
that	O
he	O
might	O
well	O
not	O
tolerate	O
that	O
and	O
suggested	O
definitive	O
chemoradiation.	O
--___:	O
Started	O
XRT	O
--___:	O
C1D1	O
cisplatin/etoposide.	O
Had	O
significant	O
light-headedness,	O
a	O
fall,	B-Falls
and	O
positive	O
orthostatics	O
throughout	O
the	O
first	O
week	O
with	O
___	O
of	O
1.5.	O
Needed	O
to	O
hold	O
D8	O
of	O
cisplatin	O
and	O
give	O
a	O
total	O
of	O
5L	O
IVF	O
over	O
two	O
days.	O
--___:	O
C2D1	O
cis/etoposide	O
--___:	O
Completed	O
XRT	O
6120	O
cGy	O
over	O
34	O
fractions.	O
PAST	O
MEDICAL/SURGICAL	O
HISTORY:	O
-Hypertension	O
-anxiety	O
-nephrolithiasis	O
-depression	O
-irritable	O
bowel	O
syndrome	O
-hep	O
B	O
-prostatitis.	O
-Latent	O
TB,	O
treated	O
in	O
___	O
with	O
nine	O
months	O
of	O
INH.	O
Social	O
History:	O
___	O
Family	O
History:	O
His	O
father	O
died	O
of	O
an	O
MI	O
at	O
age	O
___.	O
He	O
was	O
heavy	O
smoker	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
VS:	O
98.2	O
PO	O
101	O
/	O
67	O
104	O
18	O
95	O
GENERAL:	O
NAD	O
HEENT:	O
AT/NC,	O
EOMI,	O
PERRL,	O
anicteric	O
sclera,	O
MM	O
dry	O
HEART:	O
RRR,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
LUNGS:	O
CTAB,	O
no	O
wheezes,	O
rales,	O
rhonchi,	O
breathing	O
comfortably	O
without	O
use	O
of	O
accessory	O
muscles	O
ABDOMEN:	O
nondistended,	O
mild	O
tenderness	O
with	O
deep	O
palpation	O
in	O
LLQ,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
no	O
cyanosis,	O
clubbing,	O
or	O
edema	O
NEURO:	O
A&Ox3,	B-Delirium
moving	O
all	O
4	O
extremities	O
with	O
purpose	O
SKIN:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions,	O
no	O
rashes	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
VS:	O
98.1	O
___	O
GENERAL:	O
NAD	O
HEENT:	O
AT/NC,	O
EOMI,	O
PERRL,	O
anicteric	O
sclera,	O
MM	O
dry	O
HEART:	O
RRR,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
LUNGS:	O
CTAB,	O
no	O
wheezes,	O
rales,	O
rhonchi,	O
breathing	O
comfortably	O
without	O
use	O
of	O
accessory	O
muscles	O
ABDOMEN:	O
nondistended,	O
mild	O
tenderness	O
with	O
deep	O
palpation	O
in	O
LLQ,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
no	O
cyanosis,	O
clubbing,	O
or	O
edema	O
NEURO:	O
A&Ox3,	B-Delirium
moving	O
all	O
4	O
extremities	O
with	O
purpose	O
SKIN:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions,	O
no	O
rashes	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
12:00PM	O
BLOOD	O
WBC-6.6	O
RBC-3.76*	O
Hgb-9.8*	O
Hct-30.4*	O
MCV-81*	O
MCH-26.1	O
MCHC-32.2	O
RDW-15.1	O
RDWSD-44.8	O
Plt	O
___	O
___	O
12:00PM	O
BLOOD	O
Neuts-75.3*	O
Lymphs-11.1*	O
Monos-10.8	O
Eos-2.3	O
Baso-0.2	O
Im	O
___	O
AbsNeut-5.00	O
AbsLymp-0.74*	O
AbsMono-0.72	O
AbsEos-0.15	O
AbsBaso-0.01	O
___	O
12:00PM	O
BLOOD	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
___	O
PTT-30.7	O
___	O
___	O
12:00PM	O
BLOOD	O
Glucose-98	O
UreaN-22*	O
Creat-1.1	O
Na-140	O
K-4.6	O
Cl-102	O
HCO3-25	O
AnGap-13	O
___	O
12:00PM	O
BLOOD	O
CK-MB-1	O
cTropnT-<0.01	O
DISCHARGE	O
LABS:	O
___	O
07:30AM	O
BLOOD	O
WBC-9.0	O
RBC-3.84*	O
Hgb-9.9*	O
Hct-30.7*	O
MCV-80*	O
MCH-25.8*	O
MCHC-32.2	O
RDW-15.2	O
RDWSD-43.9	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
___	O
PTT-30.7	O
___	O
___	O
07:30AM	O
BLOOD	O
Glucose-99	O
UreaN-26*	O
Creat-1.1	O
Na-140	O
K-4.3	O
Cl-98	O
HCO3-25	O
AnGap-17	O
___	O
07:30AM	O
BLOOD	O
Calcium-9.5	O
Phos-3.7	O
Mg-1.6	O
MICRO:	O
___	O
12:57	O
am	O
STOOL	O
CONSISTENCY:	O
WATERY	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
(___)	O
@	O
0524AM	O
ON	O
___.	O
CLOSTRIDIUM	O
DIFFICILE.	O
Positive	O
for	O
toxigenic	O
C	O
difficile	O
by	O
the	O
Cepheid	O
nucleic	O
amplification	O
assay.	O
(Reference	O
Range-Negative).	O
___	O
7:20	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
IMAGING:	O
CXR	O
PA	O
and	O
Lateral	O
___	O
No	O
signs	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
Right	O
hilar	O
and	O
perihilar	O
scarring	O
similar	O
to	O
the	O
prior	O
CT.	O
Exercise	O
Stress	O
test	O
___:	O
INTERPRETATION:	O
This	O
___	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
stage	O
II	O
lung	O
cancer,	O
atrial	O
fibrillation,	O
hypertension,	O
dyslipidemia,	O
and	O
new	O
renal	O
mass	O
presented	O
to	O
the	O
stress	O
lab	O
from	O
the	O
___	O
Emergency	O
Department	O
for	O
the	O
evaluation	O
of	O
chest	O
pain	O
after	O
serial	O
negative	O
cardiac	O
biomarkers.	O
The	O
patient	O
exercised	O
5.25	O
minutes	O
of	O
a	O
Gervino	O
protocol	O
(3.3	O
METs,	O
poor	O
functional	O
capacity	O
for	O
age/gender)	O
and	O
the	O
test	O
was	O
terminated	O
due	O
to	O
fatigue.	O
At	O
5	O
minutes	O
of	O
exercise,	O
the	O
patient	O
related	O
the	O
onset	O
of	O
___	O
central	O
chest	O
burning	O
radiating	O
to	O
his	O
jaw	O
which	O
persisted	O
into	O
5	O
minutes	O
of	O
recovery.	O
Within	O
the	O
context	O
of	O
a	O
right	O
bundle	O
branch	O
block,	O
there	O
were	O
no	O
ischemic	O
ECG	O
changes.	O
The	O
baseline	O
rhythm	O
was	O
sinus	O
and	O
near	O
peak	O
exercise	O
there	O
were	O
several	O
short	O
runs	O
of	O
atrial	O
tachycardia	O
___	O
beats)	O
and	O
isolated	O
VPCs.	O
In	O
recovery	O
there	O
were	O
several	O
isolated	O
VPCs.	O
There	O
was	O
resting	O
asymptomatic	O
systemic	O
hypotension	O
(BP	O
86/60)	O
and	O
there	O
was	O
an	O
appropriate	O
hemodynamic	O
response	O
to	O
exercise.	O
IMPRESSION:	O
Possible	O
anginal	O
symptoms	O
without	O
ischemic	O
ECG	O
changes.	O
Echo	O
report	O
sent	O
separately.	O
ECHO	O
Stress	O
Test	O
___:	O
The	O
patient	O
exercised	O
for	O
5	O
minutes	O
and	O
15	O
seconds	O
according	O
to	O
a	O
Gervino	O
treadmill	O
protocol	O
___	O
METS)	O
reaching	O
a	O
peak	O
heart	O
rate	O
of	O
155	O
bpm	O
and	O
a	O
peak	O
blood	O
pressure	O
of	O
124/56	O
mmHg.	O
The	O
test	O
was	O
stopped	O
because	O
of	O
fatigue.	O
This	O
level	O
of	O
exercise	O
represents	O
a	O
poor	O
exercise	O
tolerance	O
for	O
age	O
and	O
gender.	O
In	O
response	O
to	O
stress,	O
the	O
ECG	O
showed	O
no	O
diagnostic	O
ST-T	O
wave	O
changes	O
(see	O
exercise	O
report	O
for	O
details).	O
There	O
is	O
a	O
low	O
resting	O
blood	O
pressure	O
with	O
normal	O
blood	O
pressure	O
and	O
heart	O
rate	O
responses	O
to	O
stress.	O
.	O
Resting	O
images	O
were	O
acquired	O
at	O
a	O
heart	O
rate	O
of	O
106	O
bpm	O
and	O
a	O
blood	O
pressure	O
of	O
86/60	O
mmHg.	O
These	O
demonstrated	O
normal	O
regional	O
and	O
global	O
left	O
ventricular	O
systolic	O
function.	O
Right	O
ventricular	O
free	O
wall	O
motion	O
is	O
normal.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Doppler	O
demonstrated	O
no	O
aortic	O
stenosis,	O
aortic	O
regurgitation	O
or	O
significant	O
mitral	O
regurgitation..	O
Echo	O
images	O
were	O
acquired	O
within	O
45	O
seconds	O
after	O
peak	O
stress	O
at	O
heart	O
rates	O
of	O
151	O
-	O
146	O
bpm.	O
These	O
demonstrated	O
appropriate	O
augmentation	O
of	O
all	O
left	O
ventricular	O
segments.	O
There	O
was	O
augmentation	O
of	O
right	O
ventricular	O
free	O
wall	O
motion.	O
IMPRESSION:	O
Poor	O
functional	O
exercise	O
capacity	O
for	O
age	O
and	O
gender.	O
No	O
ECG	O
or	O
2D	O
echocardiographic	O
evidence	O
of	O
inducible	O
ischemia	O
to	O
achieved	O
workload.	O
Resting	O
hypotension.	O
Compared	O
with	O
the	O
prior	O
study	O
(TTE	O
only	O
-	O
images	O
reviewed)	O
of	O
___,	O
the	O
findings	O
are	O
similar.	O
Brief	O
Hospital	O
Course:	O
___	O
man	O
with	O
stage	O
II	O
(T2aN1M0)	O
squamous	O
cell	O
lung	O
carcinoma	O
s/p	O
chemo/XRT	O
in	O
remission,	O
COPD,	O
paroxysmal	O
afib,	O
and	O
newly	O
diagnosed	O
renal	O
mass	O
pending	O
biopsy	O
presents	O
with	O
persistent	O
exertional	O
chest	O
pain.	O
#	O
Exertional	O
chest	O
pain:	O
Patient	O
with	O
persistent	O
exertional	O
chest	O
pain.	O
Reassuring	O
that	O
EKG	O
stable	O
from	O
prior,	O
troponin	O
negative	O
x	O
2,	O
stress	O
TTE	O
in	O
ED	O
with	O
hypotension	O
prior	O
to	O
start	O
of	O
test	O
but	O
with	O
increase	O
during	O
exercise	O
and	O
no	O
ischemic	O
changes.	O
The	O
patient	O
was	O
started	O
on	O
pravastatin	O
80mg	O
PO	O
qhs.	O
Aspirin	O
continued	O
to	O
be	O
held	O
for	O
potential	O
renal	O
biopsy	O
as	O
per	O
instructions.	O
We	O
continued	O
his	O
home	O
metoprolol	O
XL.	O
The	O
patient	O
was	O
tachycardic	O
(near	O
baseline)	O
but	O
had	O
no	O
hypoxia,	O
so	O
no	O
CTA	O
completed.	O
#	O
Renal	O
mass:	O
Plan	O
initially	O
to	O
have	O
renal	O
biopsy	O
while	O
inpatient	O
but	O
unable	O
to	O
coordinate.	O
Therefore,	O
patient	O
will	O
get	O
biopsy	O
as	O
an	O
outpatient.	O
#	O
Diarrhea:	O
Reports	O
one	O
episode	O
of	O
diarrhea	O
in	O
ED,	O
recently	O
completed	O
treatment	O
on	O
___	O
for	O
c.	O
diff	O
colitis.	O
C	O
diff	O
positive.	O
Difficult	O
to	O
elucidate	O
if	O
this	O
was	O
recurrence	O
as	O
patient	O
will	O
have	O
positive	O
PCR	O
few	O
months	O
after	O
initial	O
positive	O
result.	O
However,	O
given	O
diarrhea,	O
patient	O
started	O
on	O
MetroNIDAZOLE	O
500	O
mg	O
PO/NG	O
Q8H	O
and	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO/NG	O
Q6H.	O
The	O
patient	O
was	O
discharged	O
with	O
two	O
weeks	O
of	O
PO	O
vancomycin.	O
#	O
COPD:	O
We	O
gave	O
Duoneb	O
PRN.	O
Budesonide	O
is	O
nonformulary	O
so	O
we	O
gave	O
advair	O
while	O
in	O
house	O
#	O
Anxiety	O
We	O
continued	O
home	O
clonazepam	O
1.5	O
mg	O
BID	O
PRN	O
#	O
Depression	O
We	O
continued	O
home	O
sertraline	O
#	O
Paroxysmal	O
afib:	O
CHADS2VASC	O
3,	O
not	O
on	O
anticoagulation	O
We	O
continued	O
home	O
metoprolol.	O
Transitional	O
Issues:	O
===================	O
[	O
]	O
Monitor	O
tachycardia	O
and	O
consider	O
CTA	O
if	O
persistents	O
especially	O
given	O
underlying	O
potential	O
cancer	O
diagnosis	O
[	O
]	O
Renal	O
biopsy	O
of	O
renal	O
mass	O
as	O
an	O
outpatient	O
per	O
patient	O
preference.	O
Hold	O
aspirin	O
until	O
after	O
biopsy.	O
[	O
]	O
Discuss	O
with	O
patient	O
about	O
anticoagulation	O
given	O
elevated	O
CHADS2VASC	O
after	O
biopsy	O
[	O
]	O
If	O
diarrhea/c	O
diff	O
recurs,	O
consider	O
that	O
episode	O
as	O
a	O
___	O
recurrence	O
and	O
would	O
need	O
treatment	O
with	O
vanc/flagyl	O
[	O
]	O
new	O
medications:	O
--Pravastatin	O
40mg	O
PO	O
qpm	O
increased	O
to	O
80	O
mg	O
PO	O
QPM	O
--vancomycin	O
125mg	O
PO	O
q6h,	O
please	O
continue	O
for	O
two	O
week	O
course	O
to	O
end	O
___	O
#CODE:	O
Full	O
(confirmed)	O
#CONTACT:	O
___	O
wife	O
Phone:	O
___	O
___	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
albuterol	O
sulfate	O
90	O
mcg	O
inhalation	O
Q4H:PRN	O
Shortness	O
of	O
Breath	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
ClonazePAM	O
1.5	O
mg	O
PO	O
BID:PRN	O
anxiety	O
4.	O
Metoprolol	O
Succinate	O
XL	O
12.5	O
mg	O
PO	O
DAILY	O
5.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
6.	O
Sertraline	O
200	O
mg	O
PO	O
DAILY	O
7.	O
Budesonide	O
180	O
mcg/actuation	O
inhalation	O
DAILY	O
8.	O
Pravastatin	O
40	O
mg	O
PO	O
QPM	O
Discharge	O
Medications:	O
1.	O
Vancomycin	O
Oral	O
Liquid	O
___	O
mg	O
PO	O
Q6H	O
RX	O
*vancomycin	O
125	O
mg/2.5	O
mL	O
2.5	O
ml	O
by	O
mouth	O
every	O
6	O
hours	O
Disp	O
#*55	O
Syringe	O
Refills:*0	O
2.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
RX	O
*pravastatin	O
80	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
at	O
night	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
albuterol	O
sulfate	O
90	O
mcg	O
inhalation	O
Q4H:PRN	O
Shortness	O
of	O
Breath	O
4.	O
Budesonide	O
180	O
mcg/actuation	O
inhalation	O
DAILY	O
5.	O
ClonazePAM	O
1.5	O
mg	O
PO	O
BID:PRN	O
anxiety	O
6.	O
Metoprolol	O
Succinate	O
XL	O
12.5	O
mg	O
PO	O
DAILY	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Sertraline	O
200	O
mg	O
PO	O
DAILY	O
9.	O
HELD-	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Aspirin	O
until	O
after	O
renal	O
biopsy	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
diagnosis:	O
Clostridium	O
Difficile	O
Infection	O
Secondary	O
diagnoses:	O
stage	O
II	O
(T2aN1M0)	O
squamous	O
cell	O
lung	O
carcinoma	O
status	O
post	O
chemotherapy	O
and	O
radiation	O
therapy	O
(last	O
___	O
in	O
remission	O
Chronic	O
Obstructive	O
Pulmonary	O
Disease	O
Paroxysmal	O
atrial	O
fibrillation	O
Renal	O
mass	O
pending	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
WHY	O
WAS	O
I	O
ADMITTED?	O
You	O
were	O
admitted	O
because	O
you	O
were	O
having	O
chest	O
pain	O
WHAT	O
WAS	O
DONE	O
WHILE	O
I	O
WAS	O
HERE?	O
We	O
tested	O
your	O
heart	O
and	O
it	O
did	O
not	O
show	O
evidence	O
of	O
a	O
heart	O
attack.	O
You	O
were	O
positive	O
for	O
a	O
bacteria	O
in	O
your	O
diarrhea	O
called	O
clostridium	O
difficile	O
so	O
we	O
started	O
you	O
on	O
antibiotics	O
WHAT	O
SHOULD	O
I	O
DO	O
NOW?	O
-You	O
should	O
take	O
your	O
medications	O
as	O
instructed	O
-You	O
should	O
go	O
to	O
your	O
doctor's	O
appointments	O
as	O
below	O
-Please	O
call	O
___	O
to	O
schedule	O
your	O
renal	O
biopsy	O
We	O
wish	O
you	O
the	O
best!	O
-Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

